
Kronos Worldwide (KRO) reported a significant Q3 2025 loss of $0.18 per share, substantially missing the Zacks Consensus Estimate of a $0.06 loss and reversing last year's $0.62 earnings. Revenues of $456.9 million also fell short of expectations by 4.52% and were down year-over-year from $484.7 million. This marks a consistent trend of missing EPS estimates over the past four quarters, contributing to a 51.5% year-to-date stock decline, further compounded by the company's Chemical - Diversified industry ranking in the bottom 9% of Zacks industries.
Kronos Worldwide (KRO) reported a substantial Q3 2025 earnings miss, posting a loss of $0.18 per share against a Zacks Consensus Estimate of a $0.06 loss, marking a significant reversal from $0.62 earnings per share a year prior. Quarterly revenues of $456.9 million also fell short of consensus by 4.52% and represented a year-over-year decline from $484.7 million. This performance resulted in an earnings surprise of -200.00%. This quarter extends a pattern of underperformance, with KRO failing to surpass consensus EPS estimates for the last four quarters and missing revenue estimates in three of the past four. The stock has consequently seen a 51.5% year-to-date decline, starkly contrasting with the S&P 500's 15.6% gain over the same period. The general sentiment is strongly negative and bearish, with a moderate market impact score. Further compounding concerns, KRO operates within the Chemical - Diversified industry, which is currently positioned in the bottom 9% of Zacks-ranked industries, historically underperforming the broader market. While the stock holds a Zacks Rank #3 (Hold), suggesting market-in-line performance, the consensus EPS estimate for the coming quarter remains negative at -$0.08, with full-year EPS projected at -$0.06. Management's commentary on the earnings call will be critical for near-term price sustainability.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly negative
Sentiment Score
-0.80
Ticker Sentiment